Literature DB >> 26897420

Food and Drug Administration Drug Approval Process: A History and Overview.

Christopher Ty Williams1.   

Abstract

In this article, the processing of investigational and new drug applications is described and the standard and expedited review processes are examined. The efforts of the US Food and Drug Administration to ensure greater agency transparency and fiscal responsibility and intensify oversight during the drug development and approval process are reviewed. Often attributed to a decrease in the number of uninsured adults, both the increase in prescription drug sales and the high costs associated with bringing a new drug to market highlight the necessity for a streamlined and cost-effective process to deliver these drugs safely and effectively.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Drug approval; Drug review; Expedited reviews; Food and Drug Administration

Mesh:

Substances:

Year:  2016        PMID: 26897420     DOI: 10.1016/j.cnur.2015.10.007

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  5 in total

1.  Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.

Authors:  Ryan M Van Wagoner; Amy Eichner; Shalender Bhasin; Patricia A Deuster; Daniel Eichner
Journal:  JAMA       Date:  2017-11-28       Impact factor: 56.272

2.  Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.

Authors:  Luis F Rendon; Ishaan A Tewarie; David J Cote; Aaron Gabriel; Timothy R Smith; Marike L D Broekman; Rania A Mekary
Journal:  Drugs       Date:  2022-02-05       Impact factor: 9.546

Review 3.  Natural Products and Synthetic Analogs as a Source of Antitumor Drugs.

Authors:  Javad Sharifi-Rad; Adem Ozleyen; Tugba Boyunegmez Tumer; Charles Oluwaseun Adetunji; Nasreddine El Omari; Abdelaali Balahbib; Yasaman Taheri; Abdelhakim Bouyahya; Miquel Martorell; Natália Martins; William C Cho
Journal:  Biomolecules       Date:  2019-11-01

4.  Drug research and development opportunities in low- and middle-income countries: accelerating traditional medicine through systematic utilization and comprehensive synergy.

Authors:  Guangqi Liu; Yan Xie; Yinuo Sun; Kaixuan Zhang; Jiyan Ma; Yangmu Huang
Journal:  Infect Dis Poverty       Date:  2022-03-07       Impact factor: 4.520

5.  Trends in FDA drug approvals over last 2 decades: An observational study.

Authors:  Angelika Batta; Bhupinder Singh Kalra; Raj Khirasaria
Journal:  J Family Med Prim Care       Date:  2020-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.